Grimmer, Timo

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

Mattsson, N., Groot, C., Jansen, W. J., Landau, S. M., Villemagne, V. L., Engelborghs, S., Mintun, M. M., Lleo, A., Molinuevo, J. L., Jagust, W. J., et al. (2018) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 88

Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach

Begcevic, I., Brinc, D., Brown, M., Martinez-Morillo, E., Goldhardt, O., Grimmer, T., Magdolen, V., Batruch, I., & Diamandis, E. P. (2018) · Journal of Proteomics

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 81

Based on the network degeneration hypothesis: Separating individual patients with different neurodegenerative syndromes in a preliminary hybrid PET/MR study

Tahmasian, M., Shao, J., Meng, C., Grimmer, T., Diehl-Schmid, J., Yousefi, B. H., Förster, S., Riedl, V., Drzezga, A., & Sorg, C. (2016) · Journal of Nuclear Medicine

Dementia and Cognitive Impairment ResearchFunctional Brain Connectivity Studies

Cited by 66

Multicenter stability of resting state fMRI in the detection of Alzheimer’s disease and amnestic MCI

Teipel, S. J., Wohlert, A., Metzger, C., Grimmer, T., Sorg, C., Ewers, M., Meisenzahl, E., Klöppel, S., Borchardt, V., Grothe, M. J., et al. (2017) · NeuroImage: Clinical

Functional Brain Connectivity StudiesDementia and Cognitive Impairment Research

Cited by 62

Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease

Alexopoulos, P., Kriett, L., Haller, B., Klupp, E., Gray, K., Grimmer, T., Laskaris, N., Förster, S., Perneczky, R., Kurz, A., et al. (2014) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 62

Microglial Activation and Connectivity in Alzheimer Disease and Aging

Rauchmann, B., Brendel, M., Franzmeier, N., Trappmann, L., Zaganjori, M., Ersoezlue, E., Morenas‐Rodriguez, E., Guersel, S., Burow, L., Kurz, C., et al. (2022) · Annals of Neurology

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 61

Predicting primary progressive aphasias with support vector machine approaches in structural MRI data

Bisenius, S., Mueller, K., Diehl-Schmid, J., Fassbender, K., Grimmer, T., Jessen, F., Kassubek, J., Kornhuber, J., Landwehrmeyer, B., Ludolph, A., et al. (2017) · NeuroImage: Clinical

Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

Cited by 51

Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease

Förster, S., Yousefi, B. H., Wester, H.-J., Klupp, E., Rominger, A., Förstl, H., Kurz, A., Grimmer, T., & Drzezga, A. (2012) · European Journal of Nuclear Medicine and Molecular Imaging

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 45

Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies

Finze, A., Biechele, G., Rauchmann, B.-S., Franzmeier, N., Palleis, C., Katzdobler, S., Weidinger, E., Guersel, S., Schuster, S., Harris, S., et al. (2023) · Molecular Psychiatry

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 40

Intepirdine as adjunctive therapy to donepezil for mild‐to‐moderate Alzheimer's disease: A randomized, placebo‐controlled, phase 3 clinical trial (MINDSET)

Lang, F. M., Mo, Y., Sabbagh, M., Solomon, P., Boada, M., Jones, R. W., Frisoni, G. B., Grimmer, T., Dubois, B., Harnett, M., et al. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 34

Small vessel disease, but neither amyloid load nor metabolic deficit, is dependent on age at onset in Alzheimer’s disease.

Ortner, M., Kurz, A., Alexopoulos, P., Auer, F., Diehl-Schmid, J., Drzezga, A., Förster, S., Förstl, H., Perneczky, R., Sorg, C., et al. (2015) · Biological Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 17

Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias

EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 7